Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers

Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer

(2013) Anna Panza et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6-Mediated Paracrine Effects in Head and Neck Cancer

(2013) C.-C. Yu et al.   CANCER RESEARCH

Oncogenic role of SOX9 expression in human malignant glioma

(2012) Liang Wang et al.   MEDICAL ONCOLOGY

Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation

(2012) S Radulescu et al.   ONCOGENE

SOX9 expression and its methylation status in gastric cancer

(2012) Minhua Sun et al.   VIRCHOWS ARCHIV

Prediction of Cancer Incidence and Mortality in Korea, 2012

(2012) Kyu-Won Jung et al.   Cancer Research and Treatment

Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer

(2011) Geetika Chakravarty et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Gastrokine 1 functions as a tumor suppressor by inhibition of epithelial–mesenchymal transition in gastric cancers

(2011) Jung Hwan Yoon et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans

(2011) Miho Sashikawa Kimura et al.   JOURNAL OF GASTROENTEROLOGY

Inactivation of the Gastrokine 1 gene in gastric adenomas and carcinomas

(2010) Jung Hwan Yoon et al.   JOURNAL OF PATHOLOGY

Analysis of SOX9 Expression in Colorectal Cancer

(2008) Bingjian Lü et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

SOX9 Is Expressed in Human Fetal Prostate Epithelium and Enhances Prostate Cancer Invasion

(2008) H. Wang et al.   CANCER RESEARCH

FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD)

(2008) R Hersmus et al.   JOURNAL OF PATHOLOGY